The negative trial results have tanked the California-based biotech’s market value, with a 70% reduction in share price over ...

The US pharma giant Pfizer recently announced that its respiratory syncytial virus (RSV) vaccine Abrysvo has received FDA ...

Thermo Fisher’s John Lesica discusses how mass spectrometry technology enables scientific breakthroughs in genomics and ...

The FDA has simultaneously granted approval to Astellas’ cancer drug Vyloy and to a companion diagnostic test developed by ...

The FDA has given clearance to Adcentrx Therapeutics’ IND application for an antibody-drug conjugate (ADC) targeting solid ...

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...

From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...

A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...